查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840832

農業生物技術市場（按技術、產品類型、作物類型、應用和最終用戶分類）—2025-2032 年全球預測

Agricultural Biotechnology Market by Technology, Product Type, Crop Type, Application, End-user - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，農業生物技術市場規模將成長至 2,571.8 億美元，複合年成長率為 7.07%。

主要市場統計數據
基準年2024年 1488.1億美元
預計2025年 1586.9億美元
預測年份：2032年 2571.8億美元
複合年成長率（%） 7.07%

簡潔而全面的定位，探討塑造農業生物技術未來的科學、監管和商業性力量的融合

農業生物技術領域正處於曲折點，科學創新、不斷發展的法規和不斷變化的貿易動態正在匯聚在一起，重新定義農業實踐和商業策略：成熟的基因編輯平台、擴大微生物解決方案的應用、將高通量基因組學整合到育種管道中，以及診斷和數位工具在作物和牲畜管理中發揮越來越大的作用。

跨地區、跨商品類別的相關人員面臨著一個通用的迫切需求：將實驗室的進展轉化為可落地的解決方案，從而顯著提高作物的復原力、生產力和永續性。同時，研究中心、種子製造商和監管機構等機構參與者正在努力適應新的資料管治、智慧財產權和社會認可框架。因此，從發現到應用的道路正變得更加迭代和協作，其中生物技術公司、種苗公司和農民協會之間的夥伴關係發揮關鍵作用。

本介紹為高階主管層探索變革性轉變、政策影響、市場區隔的細微差別、區域動態、企業策略和可行建議奠定了基礎，強調需要採取一種綜合方法，平衡技術抱負與務實部署、相關人員參與以及與不斷發展的監管規範的一致性。

最近的科學突破、共同研究模式和數位診斷如何加速農業生物技術的創新並重塑其商業化路徑

農業生物技術領域正在經歷一場變革性的轉變，其驅動力在於創新，這些創新正在改變技術可行性的速度和範圍。基於 CRISPR 的基因編輯和其他精準工程工具正在縮短產生目標性狀改良所需的時間，從而實現能夠應對新型生物和生物威脅的育種週期。同時，基因組學和 DNA定序的進步使數據生成更加民主化，為育種者和研究人員提供了關於性狀結構的可行見解，並使標記輔助選擇能夠補充新的編輯方法。

微生物生物技術和合成生物學正在擴展土壤健康、養分管理和生物害蟲防治的套件，促進減少對化學投入依賴的綜合解決方案。分子診斷和數位表現型分析使得疾病和脅迫的早期檢測成為可能，從而提高了決策和管理效率。這些技術變革伴隨著制度變革：私人公司和公共研究機構之間的共同研究模式正在激增，開放資料計畫正在加速知識的傳播。

整體而言，這些轉變正在重塑產品開發路徑，縮短某些類型創新的開發時間，同時提升監管策略、公眾參與和價值鏈整合的重要性。因此，那些將研發重點與可擴展的交付模式相結合並建立相關人員信任的組織，將更有能力將科學進步轉化為商業性和社會可行的成果。

基於證據的檢驗，探討 2025 年美國關稅如何重塑農業生物技術供應鏈、國際研究合作和商業化策略。

美國2025年關稅的實施和貿易政策的調整，對農業生物技術價值鏈產生了複雜的波動，影響了投入、跨國合作以及下游商業化策略。對某些進口產品徵收關稅增加了專用實驗室試劑、昂貴育種材料和某些生物製品的直接成本，迫使製造商和研究機構重新評估籌資策略和庫存管理。為此，採購團隊已實現供應商基礎多元化，並加快了替代供應商的資格審查，以緩解眼前的衝擊。

貿易壁壘也影響了國際研究合作，導致研究機構之間生物材料和序列測定服務的轉移更加複雜，海關審查更加嚴格，前置作業時間也更長。因此，一些合作研究計劃調整了物流，更依賴國內產能和雲端基礎的資料交換，而非實體樣本運輸。此外，關稅提升了區域製造和關鍵投入品本地生產的戰略重要性，刺激了旨在建立有韌性的供應鏈和減輕貿易波動影響的投資決策。

從商業化角度來看，關稅帶來的成本壓力使得企業更重視最佳化營運效率和市場進入途徑。企業優先考慮能夠最大限度地降低跨境複雜性的產品形式和包裝，同時強調監管協調和雙邊協議，以促進貿易順暢。簡而言之，關稅環境促使企業重新評估整個農業生物技術生態系統的供應鏈彈性、合作模式和市場進入策略。

詳細的細分概述揭示了技術分類、作物分類、應用優先順序和最終用戶概況如何決定研究重點和商業化路徑

要了解市場動態，需要詳細了解技術類別、產品類型、作物重點、應用領域和最終用戶生態系統。技術領域涵蓋生物資訊學、基因工程、基因組學和分子標記、微生物生物技術、分子診斷、合成生物學和組織培養；基因工程進一步細分為 CRISPR/Cas9、基因編輯和基因改造方法，基因組學和分子標記又細分為 DNA定序和標記輔助選擇。產品類型涵蓋動物生物技術產品、生物肥料、生物農藥、基因改造作物、基因改造種子和植物生長調節劑，每種產品都需要不同的監管、生產和分銷模式。

在穀類領域，觀察大麥、玉米、稻米和小麥，可以發現育種重點和性狀組合的差異。在油籽和豆類領域，觀察油菜籽、大豆、向日葵、鷹嘴豆、扁豆和豌豆等子類別，可以發現一系列農藝和市場促進因素。應用重點在於作物改良、病害管理、環境永續性、牲畜健康和生產力以及土壤肥力管理，作物改良本身則擴展到生物脅迫耐受性、抗蟲害和產量。最終用戶範圍廣泛，從農業合作社和生物技術公司到農民和種植者、政府和監管機構、研究機構和種子製造商，每個用戶都對採用週期、購買行為和產品設計產生不同的影響。

綜上所述，這些細分揭示了技術選擇如何與作物和應用重點相互交織，從而塑造研發開發平臺和商業化路徑。例如，針對玉米非生物脅迫耐受性而客製化的基因編輯方法，與針對蔬菜系統病蟲害綜合治理而設計的微生物生物農藥，其監管途徑和最終用戶採用動態將有所不同。認知到這些微妙的相互依存關係，對於協調產品開發、相關人員參與和市場推廣策略至關重要。

美洲、歐洲、中東和非洲以及亞太地區的法規結構、基礎設施能力和招募實踐如何塑造差異化的商業化策略

區域動態對整個農業生物技術領域的技術採用模式、法規結構和商業策略有重大影響。在美洲，創新中心和成熟的種子及生物技術公司支撐著一個強大的生態系統，強調擴充性的商業化、一體化的供應鏈以及積極的公私夥伴關係研究。該地區通常引領新性狀田間試驗的部署，重點關注商品作物作物的性狀改良可以在農場層級帶來即時的效益。

歐洲、中東和非洲地區環境複雜多元，監管方式、市場接受度和生態學重點差異龐大。監管嚴格程度和公眾參與度將決定採用路徑，尤其是在基因工程和新型生物方法方面，而氣候適應和永續性目標將推動人們對以環境韌性為導向的解決方案產生興趣。同時，不同國家的市場成熟度各不相同，因此需要製定量身定做的參與策略並與相關人員進行對話。

在亞太地區，高人口密度和多樣化的種植系統使得對提高生產力、抗逆性和病害管理解決方案的需求日益迫切。一些市場正在迅速採用數位工具和診斷平台，以補充蓬勃發展的種子產業和日益成長的國內生物技術能力。在所有地區，當地法規結構、基礎設施能力和供應鏈穩健性的相互作用將決定部署的可行性和速度，因此，因地制宜成為企業策略和公共規劃的核心要素。

領先的農業生物技術公司正在利用策略性企業舉措和能力建設趨勢，將其科學平台轉變為可擴展、有彈性的商業業務

主要企業正在應對一個複雜的環境，其特點是技術創新迅速、監管審查嚴格以及客戶期望不斷變化。市場參與企業正在透過多種策略手段脫穎而出，包括對基因編輯和微生物解決方案進行有針對性的研發投資、與種苗公司和研究機構建立策略聯盟，以及進行垂直整合以確保獲得關鍵投入和分銷管道。許多公司也優先考慮監管科學能力和公共關係，以加快核准並建立相關人員的信任。

企業策略日益強調支援多條產品線的平台能力，例如模組化基因編輯套件、標準化微生物生產流程以及將基因轉導與農場管理實踐相結合的整合診斷技術。夥伴關係和授權協議在利用互補專業知識、加快測試速度和擴大商業化方面繼續發揮關鍵作用。此外，供應鏈彈性已成為董事會層面關注的重點，推動了對區域製造、裁員計畫和供應商多元化的投資。

在人才方面，企業擴大聘請由分子生物學家、監管科學家、數據分析師和田間農學家組成的多學科團隊，以連接研發和商業化。智慧財產權策略正在平衡某些領域的開放式創新模式，以促進生態系統發展，同時保護核心資產。總而言之，這些公司的舉措凸顯了企業向綜合經營模式的轉變，該模式將科學研究能力與商業性執行和相關人員的參與相結合。

為產業領導者提供明確、優先的營運和策略步驟，以加速採用、降低貿易和供應風險並協調監管和產品開發工作

產業領導者應優先考慮一系列切實可行的舉措，以利用技術進步，同時管理監管、市場和供應鏈風險。首先，在研發生命週期的早期階段納入監管策略，以協調研究設計、資料產生和公眾溝通。其次，投資區域製造和供應鏈多元化，以最大限度地減少跨境關稅波動的影響，並確保及時獲得關鍵試劑和生物投入。

第三，我們將在整個價值鏈上建立夥伴關係，包括與種子製造商、農業合作社、研究機構和服務供應商建立合作夥伴關係，共同開發能夠解決最終用戶約束和應用障礙的交付機制。第四，我們將透過將數位診斷和數據分析整合到我們的產品中，打造能夠改善檢測、決策支援和效能監控的附加價值服務，從而加強客戶維繫。第五，我們將專注於將人才培養成跨職能團隊，以應對科學、監管和商業化挑戰，同時維持適應性學習文化。

最後，我們積極與監管機構、政策制定者和民間社會相關人員合作，在安全數據、環境評估和社會經濟效益方面建立透明度。這種合作可以減少不確定性，提高公眾接受度，並為切實可行的監管協調鋪平道路，從而支持大規模的負責任創新。

透明、多學科的研究途徑結合專家訪談、文獻綜合和強力的檢驗，確保獲得可操作和檢驗的見解

本分析所採用的調查方法結合了定性和定量分析，以確保研究的穩健性、透明度和可重複性。主要研究包括對高級研發領導、監管專家、採購負責人和農民代表進行結構化訪談，以了解他們在開發平臺、供應鏈和應用動態方面的具體經驗。此外，我們還與政策專家和技術顧​​問進行了磋商，以補充這些訪談，從而為不斷發展的法律規範及其對貿易政策的影響提供背景資訊。

二次分析利用同行評審文獻、政府出版刊物、技術白皮書和公開的企業資料，對研究結果進行三角檢驗並檢驗技術聲明。資料品質保證包括交叉引用多個獨立資訊來源、檢查技術分類的一致性以及請專家審查初步結論。透過透明地記錄關於技術就緒程度、監管時間表和供應鏈配置的假設，我們認知到並解決了其中的局限性。

總體而言，該調查方法強調多學科證據綜合、相關人員檢驗和迭代改進，以便在檢驗資訊的基礎上為決策者提供可行的見解。

整合技術前景、供應鏈彈性和相關人員的參與，揭示實現農業生物技術持久影響的實用途徑

總而言之，農業生物技術領域正在發展成為一個多層面的生態系統，其成功取決於科學進步、監管條件、供應鏈韌性以及相關人員的參與。基因編輯、基因組學、微生物解決方案和數位診斷技術的融合，使得有針對性的干涉措施能夠顯著提高不同種植系統和畜牧業的韌性和生產力。然而，將科學潛力轉化為永續的市場成果，需要研發、監管、生產和市場應用等方面的策略協調。

不斷變化的貿易政策和關稅措施凸顯了供應鏈策略和本地能力的重要性。同時，按技術、產品類型、目標作物、應用和最終用戶特徵進行細分，揭示了不同的影響路徑，需要量身定做的經營模式和夥伴關係策略。投資於監管科學、本地製造和綜合服務交付，同時保持透明的相關人員參與的公司，將最有可能實現商業性和社會效益。

最終，務實的創新才是前進的方向——將技術承諾轉化為可行的部署策略、負責任的管治以及對最終用戶價值的明確關注。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 加速在耐旱玉米品種中採用 CRISPR Cas9 基因編輯
  • 擴大微生物生物肥料的市場滲透率，改善田間作物的土壤健康
  • 利用衛星整合表現型平台加速穀物性狀發現
  • 增加對植物性因組分析的投資，以開發適應氣候的作物品種
  • 將人工智慧疾病預測模型與生物技術洞察相結合，以研究病原體抗性
  • 監管協調努力影響全球基因改造油籽作物貿易
  • 開發基於奈米生物技術的種子披衣以提高豆科植物的養分吸收效率
  • 精準基因驅動與害蟲綜合管理在入侵物種控制的協同效應
  • 基於CRISPR的耐旱性狀在主要作物中的快速擴展
  • 整合人工智慧驅動的表現型分析與遙感探測，實現精準作物管理

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 農業生物技術市場（按技術）

  • 生物資訊學
  • 基因工程
    • CRISPR/Cas9和基因編輯
    • 基因工程
  • 基因組學和分子標記
    • DNA序列分析
    • 標記輔助選擇（MAS）
  • 微生物生物技術
  • 分子診斷
  • 合成生物學
  • 組織培養

9. 農業生物技術市場（依產品類型）

  • 動物生物技術產品
  • 生物肥料
  • 生物農藥
  • 基因改造作物/基因改造種子
  • 植物生長調節劑

10. 農業生物技術市場（依作物類型）

  • 序列
    • 大麥
    • 玉米
    • 米
    • 小麥
  • 水果和蔬菜
  • 油籽
    • 油菜籽
    • 大豆
    • 向日葵
  • 脈衝
    • 鷹嘴豆
    • 扁豆
    • 豌豆

第11章農業生物技術市場（按應用）

  • 作物改良
    • 非生物脅迫耐受性
    • 抗蟲害
    • 產量提高
  • 疾病管理
  • 環境永續性
  • 牲畜健康和生產力
  • 土壤肥力管理

12. 農業生物技術市場（依最終用戶）

  • 農業合作社
  • 生技公司
  • 農民和生產者
  • 政府和監管機構
  • 研究機構
  • 種子製造商

13. 農業生物技術市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章農業生物技術市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國農業生物技術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • ADAMA Ltd
    • Agrinos AS
    • Andermatt Biocontrol AG
    • Arcadia Biosciences, Inc.
    • BASF SE
    • Bayer CropScience AG
    • Bioworks, Inc.
    • Certis USA LLC
    • CIBO Technologies, Inc.
    • Corteva, Inc.
    • Evogene Ltd.
    • FMC Corporation
    • Indigo Ag, Inc.
    • Koppert Biological Systems NV
    • KWS SAAT SE & Co. KGaA
    • Limagrain
    • Marrone Bio Innovations, Inc.
    • Nufarm Limited
    • Performance Plants Inc.
    • Pivot Bio, Inc.
    • Symbiomics SA
    • Syngenta AG
    • UPL Limited
    • Valent BioSciences LLC
Product Code: MRR-221461476867

The Agricultural Biotechnology Market is projected to grow by USD 257.18 billion at a CAGR of 7.07% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 148.81 billion
Estimated Year [2025] USD 158.69 billion
Forecast Year [2032] USD 257.18 billion
CAGR (%) 7.07%

A concise yet comprehensive orientation to the converging scientific, regulatory, and commercial forces shaping the future of agricultural biotechnology

The agricultural biotechnology sector stands at an inflection point where scientific innovation, regulatory evolution, and shifting trade dynamics intersect to redefine agronomic practice and commercial strategy. This introduction synthesizes the drivers that matter most to executives and technical leaders: the maturation of gene editing platforms, expanded applications of microbial solutions, the integration of high-throughput genomics into breeding pipelines, and the increasing role of diagnostic and digital tools in crop and livestock management.

Across geographies and commodity classes, stakeholders face a common imperative to translate laboratory advances into field-ready solutions that deliver measurable improvements in resilience, productivity, and sustainability. Concurrently, institutional actors such as research centers, seed manufacturers, and regulatory agencies are navigating new frameworks for data governance, intellectual property, and public acceptance. As a result, the pathway from discovery to adoption is becoming more iterative and collaborative, with partnerships between biotech firms, seed houses, and farmer cooperatives playing a pivotal role.

This introduction sets the stage for an executive-level exploration of transformative shifts, policy impacts, market segmentation nuance, regional dynamics, corporate strategies, and actionable recommendations. It highlights the need for integrated approaches that balance technological ambition with pragmatic deployment, stakeholder engagement, and alignment to evolving regulatory norms.

How recent scientific breakthroughs, collaborative research models, and digital diagnostics are jointly accelerating innovation and reshaping commercialization pathways in agricultural biotechnology

The landscape of agricultural biotechnology is undergoing transformative shifts driven by innovations that are altering both the pace and scope of what is technically feasible. CRISPR-based gene editing and other precision engineering tools have reduced the time required to generate targeted trait improvements, enabling breeding cycles that are more responsive to emerging biotic and abiotic threats. At the same time, advances in genomics and DNA sequencing have democratized data generation, providing breeders and researchers with actionable insights into trait architecture and enabling marker-assisted selection to complement newer editing methods.

Microbial biotechnology and synthetic biology are expanding the toolkit for soil health, nutrient management, and biological pest control, fostering integrated solutions that reduce reliance on chemical inputs. Molecular diagnostics and digital phenotyping are enabling earlier detection of disease and stress, which in turn improves decision-making and management effectiveness. These technological shifts are accompanied by institutional changes: collaborative research models between private companies and public research institutions are proliferating, and open-data initiatives are accelerating knowledge diffusion.

Collectively, these shifts are reshaping product development pathways, shortening time-to-field for certain classes of innovations while increasing the importance of regulatory strategy, public engagement, and value-chain integration. As a result, organizations that align R&D priorities with scalable delivery models and stakeholder trust-building will be better positioned to translate scientific advances into commercially and socially viable outcomes.

An evidence-based examination of how the 2025 United States tariff measures reshaped supply chains, international research collaboration, and commercialization strategies across agricultural biotechnology

The imposition of tariffs and trade policy adjustments by the United States in 2025 created a complex ripple across agricultural biotechnology value chains, affecting inputs, cross-border collaborations, and downstream commercialization strategies. Tariffs on certain categories of imports raised the direct cost of specialized lab reagents, high-value breeding material, and certain bioproducts, which compelled manufacturers and research organizations to reassess sourcing strategies and inventory management. In response, procurement teams diversified supplier bases and accelerated qualification of alternate vendors to mitigate near-term disruptions.

Trade barriers also influenced international research collaborations, as increased customs scrutiny and longer lead times complicated the transfer of biological materials and sequencing services between institutions. Consequently, some collaborative projects restructured logistics to rely more on in-country capacity or cloud-based data exchange rather than physical sample transfers. Moreover, tariffs elevated the strategic importance of regional manufacturing and local production of critical inputs, prompting investment decisions aimed at building resilient supply chains and reducing exposure to trade volatility.

From a commercialization perspective, tariff-driven cost pressures sharpened the focus on operational efficiency and route-to-market optimization. Companies prioritized product formats and packaging that minimized cross-border complexities while emphasizing regulatory harmonization and bilateral agreements to facilitate smoother trade. In sum, the tariff environment catalyzed a reassessment of supply chain resilience, collaboration modalities, and market access strategies across the agricultural biotechnology ecosystem.

In-depth segmentation overview revealing how technology classes, crop categories, application priorities, and end-user profiles jointly determine research focus and commercialization pathways

Understanding market dynamics requires a granular appreciation of technology classes, product types, crop focus, application domains, and the end-user ecosystem. The technology landscape spans bioinformatics, genetic engineering, genomics and molecular markers, microbial biotechnology, molecular diagnostics, synthetic biology, and tissue culture, with genetic engineering further differentiated into CRISPR/Cas9 and gene editing versus transgenic approaches, while genomics and molecular markers extend into DNA sequencing and marker-assisted selection. Product types encompass a range from animal biotechnology products and biofertilizers to biopesticides, genetically modified crops and transgenic seeds, as well as plant growth regulators, each demanding distinct regulatory, production, and distribution models.

Crop segmentation highlights the importance of cereals, fruits and vegetables, oilseeds, and pulses; within cereals, specific attention to barley, maize, rice, and wheat reveals divergent breeding priorities and trait portfolios, and within oilseeds and pulses the subcategories of rapeseed, soybean, sunflower, chickpea, lentil, and pea illuminate varied agronomic and market drivers. Applications cluster around crop improvement, disease management, environmental sustainability, livestock health and productivity, and soil fertility management, with crop improvement itself branching into abiotic stress tolerance, pest resistance, and yield enhancement. End users range from agricultural cooperatives and biotech companies to farmers and growers, government and regulatory agencies, research institutions, and seed manufacturers, each exerting different influence on adoption cycles, purchasing behavior, and product design.

Taken together, these segmentation lenses reveal how technology choices intersect with crop and application priorities to shape R&D pipelines and commercialization paths. For example, a gene editing approach tailored for abiotic stress tolerance in maize will engage different regulatory pathways and end-user adoption dynamics than a microbial biopesticide designed for integrated pest management in vegetable systems. Recognizing these nuanced interdependencies is essential for aligning product development, stakeholder engagement, and go-to-market strategies.

How regional regulatory frameworks, infrastructure capacity, and adoption readiness across the Americas, Europe Middle East & Africa, and Asia-Pacific shape differentiated commercialization strategies

Regional dynamics materially influence technology adoption patterns, regulatory frameworks, and commercial strategies across the agricultural biotechnology landscape. In the Americas, innovation hubs and well-established seed and biotech firms anchor a robust ecosystem that emphasizes scalable commercialization, integrated supply chains, and active private-public research partnerships. This region often leads in field trial deployment for novel traits and maintains a strong emphasis on commodity-oriented crops where trait improvements deliver immediate farm-level benefits.

The Europe, Middle East & Africa region presents a heterogeneous environment where regulatory approaches, market acceptance, and agroecological priorities vary widely. Regulatory stringency and public engagement shape adoption pathways, particularly for genetic engineering and novel biologicals, while climate adaptation and sustainability goals drive interest in solutions oriented toward environmental resilience. Meanwhile, differing market maturity levels across countries necessitate tailored entry strategies and local stakeholder dialogues.

In the Asia-Pacific region, high population density and diverse cropping systems create urgent demand for productivity enhancements, stress tolerance, and disease management solutions. Rapid adoption of digital tools and diagnostic platforms in some markets complements an active seed industry and growing domestic biotech capability. Across all regions, the interplay between local regulatory frameworks, infrastructure capacity, and supply chain robustness determines the feasibility and pace of deployment, making regional adaptation a central element of corporate strategy and public policy planning.

Strategic corporate moves and capability-building trends that leading agricultural biotechnology firms use to translate scientific platforms into scalable and resilient commercial operations

Leading companies in agricultural biotechnology are navigating a complex environment marked by rapid technological change, regulatory scrutiny, and evolving customer expectations. Market participants are differentiating through several strategic levers including targeted R&D investment in gene editing and microbial solutions, strategic alliances with seed companies and research institutions, and vertical integration to secure access to critical inputs and distribution channels. Many firms are also prioritizing regulatory science capacity and public affairs to facilitate approvals and build stakeholder trust.

Corporate strategies increasingly emphasize platform capabilities that enable multiple product lines, such as modular gene editing toolkits, standardized microbial production processes, and integrated diagnostics that link trait deployment with on-farm management practices. Partnerships and licensing deals continue to play a prominent role in accessing complementary expertise, accelerating time-to-trial, and scaling commercialization. Additionally, supply chain resilience has become a board-level concern, prompting investments in regional manufacturing, redundancy planning, and vendor diversification.

From a talent perspective, firms are recruiting multidisciplinary teams that combine molecular biologists, regulatory scientists, data analysts, and field agronomists to bridge R&D and commercialization. Intellectual property strategies are being balanced with open innovation models in select domains to foster ecosystem development while protecting core assets. Collectively, these corporate moves underscore a shift toward integrated business models that couple scientific capability with commercial execution and stakeholder engagement.

Clear, prioritized operational and strategic steps for industry leaders to accelerate adoption, mitigate trade and supply risks, and align regulatory engagement with product development

Industry leaders should prioritize a set of actionable initiatives to capitalize on technological advances while managing regulatory, market, and supply chain risks. First, embed regulatory strategy early in the R&D lifecycle to align trial design, data generation, and public communication; this reduces friction at later stages and accelerates path-to-market for complex trait solutions. Second, invest in regional manufacturing and supply chain diversification to minimize exposure to cross-border tariff volatility and to ensure timely access to critical reagents and biological inputs.

Third, cultivate partnerships across the value chain, including seed manufacturers, agricultural cooperatives, research institutions, and service providers, to co-develop delivery mechanisms that address end-user constraints and adoption barriers. Fourth, integrate digital diagnostics and data analytics with product offerings to create value-added services that improve detection, decision support, and performance monitoring, thereby strengthening customer relationships and retention. Fifth, focus talent development on cross-functional teams that can navigate scientific, regulatory, and commercialization challenges while maintaining adaptive learning cultures.

Finally, proactively engage with regulators, policymakers, and civil society stakeholders to build transparency around safety data, environmental assessments, and socioeconomic benefits. Such engagement can reduce uncertainty, improve public acceptance, and create pathways for pragmatic regulatory harmonization that supports responsible innovation at scale.

A transparent, interdisciplinary research approach combining expert interviews, literature synthesis, and robust validation to ensure actionable and verifiable insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to ensure robustness, transparency, and reproducibility. Primary research included structured interviews with senior R&D leaders, regulatory specialists, procurement officers, and farmer representatives to capture lived experience across development pipelines, supply chains, and adoption dynamics. These interviews were supplemented by consultations with policy experts and technical advisers who provided context on evolving regulatory frameworks and trade policy impacts.

Secondary analysis drew upon peer-reviewed literature, government and intergovernmental publications, technical white papers, and publicly available company disclosures to triangulate findings and validate technical assertions. Data quality assurance included cross-referencing multiple independent sources, applying consistency checks to technology classification, and subjecting preliminary conclusions to expert review panels. Limitations were acknowledged and addressed by transparently documenting assumptions related to technology readiness, regulatory timelines, and supply chain configurations.

Overall, the methodological approach emphasized interdisciplinary evidence synthesis, stakeholder validation, and iterative refinement to produce insights that are practical for decision-makers while grounded in verifiable information.

Synthesis of technological promise, supply chain resilience, and stakeholder engagement that defines a pragmatic path for realizing durable impact in agricultural biotechnology

In conclusion, the agricultural biotechnology landscape is maturing into a multifaceted ecosystem where scientific advances, regulatory alignment, supply chain resilience, and stakeholder engagement determine who succeeds. The convergence of gene editing, genomics, microbial solutions, and digital diagnostics is enabling targeted interventions that can materially improve resilience and productivity across diverse cropping systems and livestock sectors. However, translating scientific potential into durable market outcomes requires strategic orchestration across R&D, regulatory affairs, manufacturing, and market adoption efforts.

Trade policy shifts and tariff measures have underscored the importance of supply chain strategy and regional capability. At the same time, segmentation by technology, product type, crop focus, application, and end-user profile reveals differentiated pathways to impact that necessitate tailored business models and partnership strategies. Firms that invest in regulatory science, regional manufacturing, and integrated service offerings while maintaining transparent stakeholder engagement will be best positioned to realize commercial and societal benefits.

Ultimately, the pathway forward is one of pragmatic innovation: aligning technological promise with feasible deployment strategies, responsible governance, and a clear focus on end-user value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Accelerating adoption of CRISPR Cas9 gene editing for drought tolerant maize varieties
  • 5.2. Expanding market penetration of microbial biofertilizers to enhance soil health in row crops
  • 5.3. Utilization of satellite integrated phenotyping platforms to accelerate trait discovery in cereals
  • 5.4. Rising investments in plant genome sequencing to unlock climate resilient crop breeds
  • 5.5. Emergence of AI driven predictive disease models combined with biotech pathogen resistance insights
  • 5.6. Regulatory harmonization efforts shaping global trade in genetically modified oilseed crops
  • 5.7. Development of nanobiotechnology based seed coatings to improve nutrient uptake efficiency in legumes
  • 5.8. Synergy between precision gene drives and integrated pest management in controlling invasive species
  • 5.9. Rapid expansion of CRISPR-based drought tolerance traits in staple crops
  • 5.10. Integration of AI-driven phenotyping and remote sensing for precision crop management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agricultural Biotechnology Market, by Technology

  • 8.1. Bioinformatics
  • 8.2. Genetic Engineering
    • 8.2.1. CRISPR/Cas9 & Gene Editing
    • 8.2.2. Transgenic Technology
  • 8.3. Genomics and Molecular Markers
    • 8.3.1. DNA Sequencing
    • 8.3.2. Marker-Assisted Selection (MAS)
  • 8.4. Microbial Biotechnology
  • 8.5. Molecular Diagnostics
  • 8.6. Synthetic Biology
  • 8.7. Tissue Culture

9. Agricultural Biotechnology Market, by Product Type

  • 9.1. Animal Biotechnology Products
  • 9.2. Biofertilizers
  • 9.3. Biopesticides
  • 9.4. Genetically Modified (GM) Crops / Transgenic Seeds
  • 9.5. Plant Growth Regulators

10. Agricultural Biotechnology Market, by Crop Type

  • 10.1. Cereals
    • 10.1.1. Barley
    • 10.1.2. Maize
    • 10.1.3. Rice
    • 10.1.4. Wheat
  • 10.2. Fruits & Vegetables
  • 10.3. Oilseeds
    • 10.3.1. Rapeseed
    • 10.3.2. Soybean
    • 10.3.3. Sunflower
  • 10.4. Pulses
    • 10.4.1. Chickpea
    • 10.4.2. Lentil
    • 10.4.3. Pea

11. Agricultural Biotechnology Market, by Application

  • 11.1. Crop Improvement
    • 11.1.1. Abiotic Stress Tolerance
    • 11.1.2. Pest Resistance
    • 11.1.3. Yield Enhancement
  • 11.2. Disease Management
  • 11.3. Environmental Sustainability
  • 11.4. Livestock Health & Productivity
  • 11.5. Soil Fertility Management

12. Agricultural Biotechnology Market, by End-user

  • 12.1. Agricultural Cooperatives
  • 12.2. Biotech Companies
  • 12.3. Farmers & Growers
  • 12.4. Government & Regulatory Agencies
  • 12.5. Research Institutions
  • 12.6. Seed Manufacturers

13. Agricultural Biotechnology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Agricultural Biotechnology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Agricultural Biotechnology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. ADAMA Ltd
    • 16.3.2. Agrinos AS
    • 16.3.3. Andermatt Biocontrol AG
    • 16.3.4. Arcadia Biosciences, Inc.
    • 16.3.5. BASF SE
    • 16.3.6. Bayer CropScience AG
    • 16.3.7. Bioworks, Inc.
    • 16.3.8. Certis USA LLC
    • 16.3.9. CIBO Technologies, Inc.
    • 16.3.10. Corteva, Inc.
    • 16.3.11. Evogene Ltd.
    • 16.3.12. FMC Corporation
    • 16.3.13. Indigo Ag, Inc.
    • 16.3.14. Koppert Biological Systems NV
    • 16.3.15. KWS SAAT SE & Co. KGaA
    • 16.3.16. Limagrain
    • 16.3.17. Marrone Bio Innovations, Inc.
    • 16.3.18. Nufarm Limited
    • 16.3.19. Performance Plants Inc.
    • 16.3.20. Pivot Bio, Inc.
    • 16.3.21. Symbiomics S.A.
    • 16.3.22. Syngenta AG
    • 16.3.23. UPL Limited
    • 16.3.24. Valent BioSciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. AGRICULTURAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. AGRICULTURAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AGRICULTURAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE,